Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02150746 · ClinicalTrials.gov registry record
Circulating Tumor Cells in Operative Blood
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 3
- Enrollment target
NCT02150746 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 3 participants.
The verdict
NCT02150746 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 3 participants
- Enrollment target
Study Summary
It is hypothesized that circulating tumor cells (CTCs) from pancreatic adenocarcinoma are released into the peritoneal cavity through blood lost during the surgical resection of these tumors resulting in peritoneal recurrence despite appropriate surgical resection. Targeting the mechanisms responsible for CTC adhesion to the peritoneum may result in inhibition of implantation and growth, thus preventing this mode of pancreatic cancer recurrence postoperatively.
Interventions
- PROCEDURE Peripheral/Central Venous Blood Draw
- PROCEDURE Peritoneal Wash
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2015-02 |
| Est. Completion | 2016-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02150746
The ClinicalTrials.gov registry entry for NCT02150746 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Peripheral/Central Venous Blood Draw is the first listed.
NCT02150746 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02150746 about?
NCT02150746 is a clinical study titled "Circulating Tumor Cells in Operative Blood". It is hypothesized that circulating tumor cells (CTCs) from pancreatic adenocarcinoma are released into the peritoneal cavity through blood lost during the surgical resection of these tumors resulting in peritoneal recurrence despite appropriate surgical resection. Targeting the mechanisms responsib...
What is the current status of trial NCT02150746?
This trial is currently completed. The enrollment target is 3 participants. The study started on 2015-02. Estimated completion is 2016-02.
What interventions are being tested in trial NCT02150746?
The interventions under investigation include: Peripheral/Central Venous Blood Draw (PROCEDURE), Peritoneal Wash (PROCEDURE).
Who is sponsoring clinical trial NCT02150746?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.